{'fraction_non_alphanumeric': 0.026837806301050177, 'fraction_numerical': 0.0, 'mean_word_length': 6.032786885245901, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Management of congenital heart disease.

Management of CHD depends on the type, severity, natural history of the specific malformation, age and the secondary effect of the defect. Management includes diagnostic, regular follow-ups, preventive and therapeutic management. Prevention measures should be taken against infective endocarditis, brain abscess, pulmonary vascular obstructive disease (PVOD). Therapeutic measures include treatment for cardiac failure, infective endocarditis, common infections, arrhythmia, cyanotic spells, cerebro vascular complications. Early correction is indicated for CHD with large pulmonary blood flow to prevent PVOD, and for CHD with pressure overloading to prevent fibrosis of the myocardium. Cyanotic CHD should have early palliative or corrective surgery in order to minimise the secondary effect of prolonged cyanosis.